Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ribose (Furanose) SCHEMBL15531966 | 0.67 | LGALS1 (0.52) | MAPTKDM4ELMNACYP2D6CYP2C19 | |
| Dextrose SCHEMBL3364163 | 0.65 | LGALS3 (0.56) | MAPTLMNA | |
| Dextrose SCHEMBL30912332 | 0.65 | LGALS3 (0.56) | MAPTLMNA | |
| D-Galactose SCHEMBL4243715 | 0.65 | LGALS3 (0.56) | MAPTLMNA | |
| B-D-Galactose SCHEMBL364282 | 0.65 | LGALS3 (0.56) | MAPTLMNA | |
| B-D-Galactose SCHEMBL3939815 | 0.65 | LGALS3 (0.56) | MAPTLMNA | |
| D-Allose SCHEMBL29540485 | 0.65 | LGALS3 (0.56) | MAPTLMNA | |
| Beta-D-Glucose SCHEMBL2763115 | 0.65 | LGALS3 (0.56) | MAPTLMNA | |
| Dextrose SCHEMBL30949013 | 0.65 | LGALS3 (0.56) | MAPTLMNA | |
| B-D-Galactose SCHEMBL27583177 | 0.65 | LGALS3 (0.56) | MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6670193-B2 | Coupling with organometallic compound; emission light | RESEARCH CORPORATION TECHNOLOGIES, INC. | 2003-12-30 | — | — | US | disclosed |
| US-6479650-B1 | Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same | RESEARCH CORPORATION TECHNOLOGIES, INC. | 2002-11-12 | — | — | US | disclosed |
| US-20020160411-A1 | Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 2002-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020160411-A1 | Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same | DERA, FBL, DUT | MAPT 4335/4885MAPK1 1605/4885KDM4E 2766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.